Related Experiment Video
Updated: Sep 13, 2025

A Simplified Stepwise Approach to Echo Guidance during Percutaneous Mitral Valve Repair
Published on: October 16, 2021
Midterm Outcomes of Pediatric Mitral Valvuloplasty for Moderate to Severe Mitral Valve Regurgitation and Associated
Hongyuan Fu1, Aijun Liu1, Ming Yang1
1Pediatric Cardiovascular Center, Capital Medical University Affiliated Anzhen Hospital, Beijing, China.
Insights
Mitral valvuloplasty effectively treats pediatric mitral valve regurgitation, showing significant improvement and low mortality. Early intervention is key to prevent long-term valve deterioration in children.
Area of Science:
- Cardiology
- Pediatric Cardiac Surgery
- Interventional Cardiology
Background:
- Mitral valve regurgitation (MVR) in children often requires intervention.
- Mitral valvuloplasty is a primary treatment option for pediatric MVR.
- Identifying risk factors for MVR progression post-procedure is crucial.
Purpose of the Study:
- To identify risk factors for mitral valve regurgitation progression after valvuloplasty in pediatric patients.
- To evaluate the effectiveness of mitral valvuloplasty in treating pediatric MVR.
- To assess long-term outcomes and prognosis following the procedure.
Main Methods:
- Retrospective, single-center study of 137 pediatric patients with moderate to severe MVR.
- Kaplan-Meier analysis for freedom from MVR deterioration and cardiovascular death.
- Univariate and multivariate Cox regression to identify independent risk factors.
Main Results:
- Mitral valvuloplasty significantly reduced MVR severity (P < .001).
- Midterm follow-up showed 89.4% freedom from MVR worsening and 97.5% freedom from cardiovascular death.
- Independent risk factors for deterioration included body weight, LV end-diastolic diameter, LV ejection fraction, and cardiopulmonary bypass time.
Conclusions:
- Mitral valvuloplasty offers low mortality and positive long-term outcomes for pediatric MVR.
- Early, aggressive treatment is recommended to mitigate late postoperative valve deterioration.
- Factors like higher body weight and larger ventricular septal defects correlate with worse outcomes.
Background:
Mitral valvuloplasty is considered the best treatment for pediatric mitral valve regurgitation. The objective of this analysis was to identify risk factors for postoperative mitral valve regurgitation progression and evaluate valvuloplasty effectiveness.
Methods:
This retrospective, single-center study investigated the clinical efficacy of mitral valvuloplasty and identified factors that affect prognosis. Pediatric patients with moderate or severe mitral valve regurgitation who had undergone mitral valvuloplasty between September 2016 and August 2023 were included. Kaplan-Meier survival analysis was used to assess freedom from both mitral valve deterioration and cardiovascular death. Univariate and multivariate Cox regression analyses were performed to identify potential risk factors.
Results:
The study comprised 137 pediatric patients (mean age, 37.5 months [range, 2.4-167.6 months]) who had moderate (64/137 [46.7%]) or severe (73.137 [53.3%]) mitral valve regurgitation. At midterm follow-up (median, 55.3 months), mitral valve regurgitation had statistically significantly decreased compared with preoperative levels (P < .001, Wilcoxon signed-rank test); freedom from cardiovascular death was 97.5%, and freedom from worsening mitral valve regurgitation was 89.4%. Cox regression analysis identified body weight (P = .02), left ventricular end-diastolic diameter (P = .005), and left ventricular ejection fraction (P = .01) at 1 month and cardiopulmonary bypass time (P = .007) as independent risk factors for deterioration. Patients weighing 10 kg or more (P = .04) or with a ventricular septal defect 8 mm or larger (P = .04) had worse outcomes.
Conclusion:
Mitral valvuloplasty resulted in low mortality and positive long-term results in pediatric patients with mitral valve regurgitation. Early aggressive therapy is recommended to avoid late postoperative mitral valve deterioration.
Related Concept Videos
Mitral Regurgitation IV: Nursing Management
Mitral Valve Prolapse II: Assessment and Management
Mitral Regurgitation III: Medical Management
Mitral Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Valve Prolapse I: Introduction
Mitral Stenosis III: Medical Management

